Implementation of a prehospital air medical thawed plasma program: Is it even feasible?

Background: The Prehospital Air Medical Plasma (PAMPer) trial demonstrated a 30-day survival benefit among hypotensive trauma patients treated with prehospital plasma during air medical transport. We characterized resources, costs and feasibility of air medical prehospital plasma program implementation.

Methods: We performed a secondary analysis using data derived from the recent PAMPer trial.